Items where authors include "Kakkar, V."

Article

Di Donato, S. orcid.org/0000-0003-1256-0761, Ross, R., Karanth, R. et al. (7 more authors) (2025) Serum Type I Interferon Score predicts clinically meaningful disease progression in limited cutaneous Systemic Sclerosis. Arthritis & Rheumatology. ISSN 2326-5191

Roth, E., Bruni, C., Petelytska, L. et al. (244 more authors) (2025) Gastroesophageal reflux disease is associated with a more severe interstitial lung disease in systemic sclerosis in the EUSTAR cohort. Rheumatology. keaf016. ISSN 1462-0324

Ross, R.L., Caballero-Ruiz, B., Clarke, E.L. et al. (11 more authors) (2024) Biological hallmarks of systemic sclerosis are present in the skin and serum of patients with Very Early Diagnosis of SSc (VEDOSS). Rheumatology. keae698. ISSN 1462-0324

De Lorenzis, E., Natalello, G., Pellegrino, G. et al. (29 more authors) (2024) Long-term retention rate, adverse event temporal patterns and rescue treatment strategies of mycophenolate mofetil in systemic sclerosis: insights from real-life. Rheumatology. keae532. ISSN 1462-0324

De Lorenzis, E., Del Galdo, F., Natalello, G. et al. (10 more authors) (2024) Concordance and Prognostic Relevance of Different Definitions of Systemic Sclerosis Interstitial Lung Disease Progression. American Journal of Respiratory and Critical Care Medicine. ISSN 1073-449X

Wasson, C., Dibb, S., Bryon, J. et al. (8 more authors) (2024) P27 Chloride intracellular channel 4 is a global regulator of type 1 interferon signalling in systemic sclerosis skin. British Journal of Dermatology, 190 (6). e91-e92. ISSN 0007-0963

De Lorenzis, E. orcid.org/0000-0001-9819-105X, Kakkar, V., Di Donato, S. et al. (13 more authors) (2024) Clinical trajectories of hand function impairment in systemic sclerosis: an unmet clinical need across disease subsets. RMD Open, 10 (1). e003216. ISSN 2056-5933

Kakkar, V., Assassi, S., Allanore, Y. et al. (4 more authors) (2022) Type 1 interferon activation in systemic sclerosis: a biomarker, a target or the culprit. Current Opinion in Rheumatology, 34 (6). pp. 357-364. ISSN 1040-8711

Conference or Workshop Item

DI Donato, S., Ross, R., Karanth, R. et al. (6 more authors) (2024) OP0314 Interferon score as a novel trial enrichment tool to predict clinical outcomes in patients with limited cutaneous systemic sclerosis. In: EULAR 2024 European Congress of Rheumatology, 12-15 Jun 2024, Vienna, Austria.

De Lorenzis, E., Natalello, G., Di Donato, S. et al. (6 more authors) (2023) AB0841 concordance and prognostic relevance of different definitions of systemic sclerosis interstitial lung disease progression. In: EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy.

De Lorenzis, E., Kakkar, V., Di Donato, S. et al. (13 more authors) (2023) AB0881 clinical trajectories of multifactorial hand function deterioration in systemic sclerosis. In: EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy.

Proceedings Paper

Di Donato, S., Hughes, M., Geloshi, K. et al. (6 more authors) (2023) P156 Evidence of Type I interferon activation during vascular manifestations of systemic sclerosis. In: Rheumatology. British Society for Rheumatology Annual Conference 2023, 24-26 Apr 2023, Manchester, UK. Oxford University Press .

De Lorenzis, E., Kakkar, V., Di Donato, S. et al. (4 more authors) (2023) P159 Clinical trajectories and predictors of hand function deterioration in systemic sclerosis. In: Rheumatology. British Society for Rheumatology Annual Conference 2023, 24-26 Apr 2023, Manchester, UK. Oxford University Press .

De Lorenzis, E., Kakkar, V., Ross, R. et al. (11 more authors) (2022) POS0876 Serum Interferon Score Predicts Severity Of Patient Reported Hand Disability In Systemic Sclerosis. In: Annals of the Rheumatic Diseases. EULAR 2022 European Congress of Rheumatology, 01-04 Jun 2022, Copenhagen, Denmark. BMJ , pp. 733-734.